![](/img/cover-not-exists.png)
INTERIM DATA FROM THE FIRST CLINICAL STUDY OF ADCT-301, A NOVEL PYRROLOBENZODIAZAPINE-BASED ANTIBODY DRUG CONJUGATE, IN RELAPSED/REFRACTORY HODGKIN/NON-HODGKIN LYMPHOMA
Horwitz, S.M., Fanale, M.A., Spira, A.I., Havenith, K., He, S., Feingold, J.M., Hamadani, M.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_143
Date:
June, 2017
File:
PDF, 192 KB
english, 2017